Article

Pharmacogenomic and drug interaction risk associations with hospital length of stay among Medicare Advantage members with COVID-19

2021-05-13

Abstract excerpt

<h4>Importance</h4> COVID-19 has severely impacted older populations and strained healthcare resources, with many patients requiring long periods of hospitalization. Reducing the hospital length of stay (LOS) reduces patient and hospital burden. Given that adverse drug reactions are known to prolong LOS, unmanaged pharmacogenomic risk and drug interactions among COVID-19 patients may be a risk factor for longer ho...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d3f25e72-a019-57f1-b4b0-ad1e13650063
DOI: 10.1101/2021.05.06.21256769

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomic and drug interaction risk associations with hospital length of stay among Medicare Advantage members with COVID-19DOI 10.1101/2021.05.06.21256769Read

A protocol for assessment of interventions using a computational phenotype for Long COVIDSemantic proximity Read

A novel multi-omics-based identification of symptoms, comorbid conditions, and possible long-term complications in COVID-19Semantic proximity Read

Seek COVER: Development and validation of a personalized risk calculator for COVID-19 outcomes in an international networkSemantic proximity Read

Effect of Dapagliflozin on COVID-19 Infection and Risk of HospitalizationSemantic proximity Read

Examination of Medication Use Patterns by Age Group, Comorbidity, and Month in COVID-19 Positive Patients in a Large State-wide Health System During the Pandemic in 2020Semantic proximity Read

The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare SystemSemantic proximity Read

Exploring drugs and vaccines associated with altered risks and severity of COVID-19: a UK Biobank cohort study of all ATC level-4 drug categoriesSemantic proximity Read

Severity of COVID-19 Infection in ACEI/ARB Users in Two Saudi Public Specialty Hospitals; Retrospective Cohort StudySemantic proximity Read

Covid-19 and Excess Mortality in Medicare BeneficiariesSemantic proximity Read

Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital mortalitySemantic proximity Read

Mortality and Transitions-Of-Care After COVID-19 Hospitalization Among US Medicare Patients: A Retrospective Claims AnalysisSemantic proximity Read

Real-world Effectiveness of Casirivimab and Imdevimab in Patients With COVID-19 in the Ambulatory Setting: An Analysis of Two Large US National Claims DatabasesSemantic proximity Read